Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Gene fusions involving ALK, ROS1, RET, and NTRK are now established targets in NSCLC, for which highly effective and well-tolerated kinase inhibitors are the...

  • Gene fusions are established targets in #NSCLC, for which highly effective & well-tolerated kinase inhibitors are the preferred initial therapy. A growing body of evidence suggests fusions in NRG1 will emerge as another relevant genomic target. More: https://t.co/iuTtXgZWrt #LCSM - view on twitter

Mashup Score:3

lww.com

Wolters Kluwer Health - 23 hours

Mashup Score:3

JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers:...